2026. Serum Interleukin-39 as an Emerging Inflammatory Biomarker in Diabetes Mellitus: Evidence from ROC Curve Analysis. Chemical Interactions. 2, 1 (Feb. 2026). DOI:https://doi.org/10.64354/4nx8w333.